Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemocompatibility testing of polymers]

U T Seyfert1, S Perkins, M Kümmel

  • 1Abteilung Klinische Haemostaseologie und Transfusionsmedizin Universitäts-kliniken des Saarlandes, Homburg, Deutschland.

Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine
|January 1, 1996
PubMed
Summary

Haemoincompatibility from artificial materials hinders artificial organ development. A new scoring system and ex vivo models effectively assess polymer haemocompatibility, guiding material selection for medical devices.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A descriptive analysis of an outbreak of measles and a multilevel mixed-effects analysis of factors associated with case isolation in healthcare settings, London (February-June 2016).

Public health·2020
Same author

Burden of multidrug-resistant tuberculosis in England: a focus on prevalent cases.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Expected background rates of latent TB infection in London inner city schools: lessons from a TB contact investigation exercise in a secondary school.

Epidemiology and infection·2018
Same author

Participation in research improves overall patient management: insights from the Global Rheumatic Heart Disease registry (REMEDY).

Cardiovascular journal of Africa·2018
Same author

SU-E-T-593: VMAT Vs. IMRT for Treatment of Neoplasms of the Brain: Dosimetric Quality and Delivery.

Medical physics·2017
Same author

HNO·2017

Area of Science:

  • Biomaterials Science
  • Medical Device Engineering
  • Hematology

Background:

  • Haemoincompatibility, caused by artificial materials, is a significant barrier to artificial organ development and causes morbidity in patients requiring extracorporeal circulation or catheterization.
  • The interaction between blood and synthetic surfaces remains a critical challenge in medical technology.
  • Understanding and mitigating adverse blood-material interactions is essential for improving patient outcomes.

Purpose of the Study:

  • To develop and validate models for characterizing the ex vivo haemocompatibility of different polymers.
  • To establish a scoring system for quantifying material haemocompatibility.
  • To highlight the importance of considering flow characteristics and preanalytical effects in haemocompatibility testing.

Main Methods:

Related Experiment Videos

  • Development of novel ex vivo models for material testing.
  • Implementation of a comprehensive scoring system (0-60 scorepoints) to evaluate haemocompatibility.
  • Analysis of polymer interactions with blood under controlled conditions.

Main Results:

  • The developed models successfully characterized the ex vivo haemocompatibility of various polymers.
  • The scoring system provides a quantitative measure for assessing material suitability.
  • Demonstrated the significant impact of flow dynamics and preanalytical factors on test outcomes.

Conclusions:

  • The established ex vivo models and scoring system offer a reliable method for assessing polymer haemocompatibility.
  • Accurate material selection is crucial for reducing haemoincompatibility-related complications in medical devices.
  • Future research should integrate comprehensive testing protocols that account for physiological conditions.